These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 9150953)

  • 1. Simultaneous analysis of cyclin and oncogene expression using multiple monoclonal antibody immunoblots.
    Sanchez JC; Wirth P; Jaccoud S; Appel RD; Sarto C; Wilkins MR; Hochstrasser DF
    Electrophoresis; 1997; 18(3-4):638-41. PubMed ID: 9150953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deregulated expression of p27(Kip1) in human breast cancers.
    Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
    Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of CDKN2A, CDKN2B, CDKN2C, and cyclin Ds gene status in hepatoblastoma.
    Iolascon A; Giordani L; Moretti A; Basso G; Borriello A; Della Ragione F
    Hepatology; 1998 Apr; 27(4):989-95. PubMed ID: 9537438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
    Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
    Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
    Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells.
    Srivastava P; Russo J; Mgbonyebi OP; Russo IH
    Anticancer Res; 1998; 18(6A):4003-10. PubMed ID: 9891438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle dysregulation influences survival in high risk breast cancer patients.
    Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C
    Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome- and microarray-based expression analysis of lymphoma cell lines identifies a p53-centered cluster of differentially expressed proteins in mantle cell and follicular lymphoma.
    Weinkauf M; Christopeit M; Hiddemann W; Dreyling M
    Electrophoresis; 2007 Dec; 28(23):4416-26. PubMed ID: 17990259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in epitope accessibility of p53 monoclonal antibodies suggest at least three conformations or states of protein binding of p53 protein in human tumor cell lines.
    Danks MK; Whipple DO; McPake CR; Lu D; Harris LC
    Cell Death Differ; 1998 Aug; 5(8):678-86. PubMed ID: 10200523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
    Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
    Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of proliferating cell nuclear antigen (PCNA) isoforms in normal and cancer cells: there is no cancer-associated form of PCNA.
    Naryzhny SN; Lee H
    FEBS Lett; 2007 Oct; 581(25):4917-20. PubMed ID: 17900571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein profiles and identification of high performance liquid chromatography isolated proteins of cancer cell lines using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Chong BE; Lubman DM; Rosenspire A; Miller F
    Rapid Commun Mass Spectrom; 1998; 12(24):1986-93. PubMed ID: 10036781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene.
    Pietras RJ; Poen JC; Gallardo D; Wongvipat PN; Lee HJ; Slamon DJ
    Cancer Res; 1999 Mar; 59(6):1347-55. PubMed ID: 10096569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy.
    Bartkova J; Rajpert-de Meyts E; Skakkebaek NE; Bartek J
    J Pathol; 1999 Apr; 187(5):573-81. PubMed ID: 10398124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogene expression as detected by immunocytochemical staining in hormonally induced ovarian cell lines.
    Luthra K; Chapekar TN
    Indian J Exp Biol; 1998 May; 36(5):447-55. PubMed ID: 9717461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of cell cycle progression in human mesothelioma cells treated with gamma interferon.
    Vivo C; Lévy F; Pilatte Y; Fleury-Feith J; Chrétien P; Monnet I; Kheuang L; Jaurand MC
    Oncogene; 2001 Mar; 20(9):1085-93. PubMed ID: 11314045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle gene regulation in reversibly differentiated new human hepatoma cell lines.
    Glaise D; Ilyin GP; Loyer P; Cariou S; Bilodeau M; Lucas J; Puisieux A; Ozturk M; Guguen-Guillouzo C
    Cell Growth Differ; 1998 Feb; 9(2):165-76. PubMed ID: 9486853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach.
    Li R; Wang H; Bekele BN; Yin Z; Caraway NP; Katz RL; Stass SA; Jiang F
    Oncogene; 2006 Apr; 25(18):2628-35. PubMed ID: 16369491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.